Independent
Tenure on this board
11.0 yrs
Also a director at
Grid Dynamics Holdings Inc (GDYN)Vertex Pharmaceuticals Inc (VRTX)
11 nominees.
Visa's 2026 proxy includes four shareholder proposals (Independent Chair, Written Consent, Online Exploitation Reporting, Inclusion ROI Audit) opposed by the Board; proponents include National Legal and Policy Center, John Chevedden, Bowyer Research on the Oklahoma Tobacco Settlement Endowment Trust, and the National Center for Public Policy Research.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0% | 107,005,168 | $32.3B |
| 2 | STATE STREET CORP | 4.6% | 82,306,015 | $24.9B |
| 3 | BlackRock, Inc. | 3.0% | 53,276,829 | $16.1B |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 39,630,322 | $12.0B |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.2% | 38,662,589 | $11.7B |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.1% | 37,604,815 | $11.4B |
| 7 | BlackRock, Inc. | 2.0% | 35,278,578 | $10.7B |
| 8 | TCI Fund Management LtdActivist | 1.7% | 30,468,133 | $9.2B |
| 9 | FMR LLC | 1.5% | 26,607,614 | $8.0B |
| 10 | Capital World Investors | 1.4% | 25,178,201 | $7.6B |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.